Prudent Natural Products Profile
Key Indicators
- Authorised Capital ₹ 3.30 Cr
as on 17-12-2024
- Paid Up Capital ₹ 2.80 Cr
as on 17-12-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 2.65 Cr
as on 17-12-2024
- Revenue %
(FY 2019)
- Profit 74936.74%
(FY 2019)
- Ebitda -0.74%
(FY 2019)
- Net Worth 105.84%
(FY 2019)
- Total Assets -38.06%
(FY 2019)
About Prudent Natural Products
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 3.30 Cr and a paid-up capital of Rs 2.80 Cr.
The company has closed loans amounting to ₹2.65 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nilesh Mehta and Sevantilal Champaneri serve as directors at the Company.
- CIN/LLPIN
U01119MH2002PTC250663
- Company No.
250663
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2002
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Prudent Natural Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Mehta  | Director | 01-Jun-2012 | Current |
| Sevantilal Champaneri | Director | 01-Jun-2012 | Current |
Financial Performance and Corporate Structure Insights of Prudent Natural Products.
Prudent Natural Products Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 74936.74% increase in profit. The company's net worth Soared by an impressive increase of 105.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prudent Natural Products?
In 2019, Prudent Natural Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Royal Pharmaceuticals Industries Private LimitedActive 2 years 10 months
Nilesh Mehta and Sevantilal Champaneri are mutual person
- Royal Pharma Private LimitedInactive For E-Filing 7 months
Nilesh Mehta and Sevantilal Champaneri are mutual person
- Legaltors Realiinfra Private LimitedActive 5 years 8 months
Sevantilal Champaneri is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 05 Apr 2005 | ₹2.65 Cr | Satisfied |
How Many Employees Work at Prudent Natural Products?
Unlock and access historical data on people associated with Prudent Natural Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prudent Natural Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prudent Natural Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
